Health Condition 1: H578- Other specified disorders of eye and adnexa
Conditions
Interventions
Intervention1: Intra nasal Dexmedetomidine dosage 0.5mcg/kg: Intra nasal Dexmedetomidine dosage 0.5mcg/kg given half an hour prior to induction for 30patients.
Total duration of study is 6months
Sponsors
Nethradhama Super Speciality Eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Children for eye surgery ASA 1 & 2
Exclusion criteria
Exclusion criteria: Patient refusal, known allergy to Dexmedetomidine, Any obvious aberrant nasal deformity, acute or chronic nasal trauma that may preclude adequate intranasal delivery of drug, Patients with anticipated difficult airway and obese, Renal and liver dysfunction, cardiovascular disease including bradycardia, respiratory disease, infection, Drowsy on the day of surgery with Ramsay Level of Sedation Score >3
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative assessment of the effect of intra nasal dexmedetomidine pre-operatively in children undergoing eye surgery given intranasally at dose 0.25mcg/kg or 0.5mcg/kgTimepoint: 6months | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effect associated with intranasal dexmedetomidine given at 0.25mcg/kg & 0.5mcg/kgTimepoint: 6months | — |
Countries
India
Contacts
Public ContactDr Suman Shree Ramaswamy
Nethradhama Super speciality Eye hospital
Outcome results
None listed